Announcement
01 Dec 2025
In December 2025, the UK Government announced its commitments under an agreement on pharmaceuticals with the United States.
Source
Sign in to access
Number of interventions
1
0 certainly harmful
1 likely harmful
0 liberalising
List of interventions
Implementation date
No implementation date
Revocation date:
No revocation date
Announced: 01 Dec 2025
Instrument unclear
On 1 December 2025, the UK Government announced a pharmaceuticals agreement with the United States under the UK–US Economic Prosperity Deal. As part of the agreement, the UK made commitments that will...
Sign in to see more
Related State Acts
Announced: 01 Dec 2025
United States of America: U.S. Administration’s commitments under an agreement on pharmaceutical pricing with the United Kingdom
Announced: 08 May 2025
United States of America: US Administration's commitments under "Economic Prosperity Deal" with the United Kingdom
Announced: 08 May 2025
United Kingdom: UK Government's commitments under "Economic Prosperity Deal" with the United States
Implemented: 02 Apr 2026
United States of America: U.S. Administration imposes Section 232 tariffs on pharmaceutical imports
Threads
See all
United States: Drug Pricing Agreements
This Thread tracks the U.S. Administration’s agreements with pharmaceutical companies. It is based on the Executive Order titled “Delivering Most-Favored-Nation (MFN) Prescription Drug Pricing to American Patients.” These agreements include tariff relief measures for pharmaceutical companies in return for their commitments to implement most-favored-nation pricing for their drugs and to invest i...
Published: 11 Nov 2025
68
interventions
2
jurisdictions
Harmful Trade Policy Measures
This Thread tracks harmful trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
70711
interventions
194
jurisdictions